The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with melanoma progressing on or after a PD-1/L1 blocking antibody.
 
Sanjiv S. Agarwala
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Stergios J. Moschos
Consulting or Advisory Role - Amgen; Castle Biosciences; Merck Sharp & Dohme; Prometheus
Research Funding - Amgen; Genentech/Roche; Merck Sharp & Dohme; Pharmacyclics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
 
Melissa Lynne Johnson
Consulting or Advisory Role - Astellas Pharma (I); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Genentech/Roche (Inst); Otsuka (I)
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Checkpoint Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Foundation Medicine (Inst); Genmab (Inst); Guardant Health (Inst); Hengrui Pharmaceutical (Inst); Janssen (Inst); Kadmon (Inst); Lilly (Inst); Loxo (Inst); Lycera (Inst); Merck (Inst); Mersana (Inst); Mirati Therapeutics (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Stem CentRx (Inst); Tarveda Therapeutics (Inst)
 
Mateusz Opyrchal
Consulting or Advisory Role - AstraZeneca
Research Funding - Pfizer
 
Dmitry Gabrilovich
Consulting or Advisory Role - Janssen Oncology; Peregrine Pharmaceuticals; Syndax
Research Funding - Biothera; Bristol-Myers Squibb; Galera Therapeutics; Janssen Oncology; Syndax
 
Patrick Danaher
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Fang Wang
No Relationships to Disclose
 
Susan Brouwer
Employment - Syndax
Stock and Other Ownership Interests - Syndax
 
Peter Ordentlich
Employment - Syndax
Leadership - Syndax
Stock and Other Ownership Interests - Syndax
 
Serap Sankoh
Employment - Syndax
Stock and Other Ownership Interests - Syndax
 
Emmett V. Schmidt
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michael L. Meyers
Employment - Syndax
Leadership - Syndax
Stock and Other Ownership Interests - Syndax
 
Ryan J. Sullivan
Honoraria - Roche/Genentech
Consulting or Advisory Role - ACI Clinical; Amgen; Array BioPharma; Biodesix; BiolineRx; Merck; Novartis; Takeda; WorldCare Clinical, LLC
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Other Relationship - Boehringer Ingelheim